Advertisement

Topics

Groupe Pierre Fabre Company Profile

01:25 EDT 26th September 2017 | BioPortfolio

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 R&D staff, and generates a sales turnover of EUR1.8 billion.


News Articles [80 Associated News Articles listed on BioPortfolio]

Pierre Fabre to commercialize Aprotecol in Italy

Spain-based Noventure and the Italian subsidiary of France’s Pierre Fabre have entered into an agreement…

Pierre Fabre sets sights on bigger I-O business

Privately-held Pierre Fabre Pharmaceuticals is buying immuno-oncological candidates from Igenica Biotherapeutics,…

Pierre Fabre Acquires Ingenica Immuno-Oncology Assets

Pierre Fabre said today it has agreed to acquire “several” cancer immunotherapies from Igenica Biotherapeutics for an undisclosed price, in a deal designed to strengthen the buyer’s oncology pip...

Pierre Fabre Acquires Igenica Immuno-Oncology Assets

Pierre Fabre said today it has agreed to acquire “several” cancer immunotherapies from Igenica Biotherapeutics for an undisclosed price, in a deal designed to strengthen the buyer’s oncology pip...

Pierre Fabre Buys Igenica Immuno-oncology Assets

Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area

Pierre Fabre secures Italian distribution rights for Noventure's Aprotecol

Noventure has allied with Pierre Fabre Pharma Italy in a partnership which will see the latter distribute the Spanish start-up’s paediatric intestinal treatment Aprotecol in Italy. read more

Pierre Fabre to buy Igenica Biotherapeutics’ assets for treating cancer patients

French private pharmaceutical group Pierre Fabre has signed a new definitive purchase agreement to acquire several assets from US biotechnology company Igenica Biotherapeutics.

Pierre Fabre acquires immuno-oncology assets from Igenica

Pierre Fabre Group acquired certain immuno-oncology assets from Igenica Biotherapeutics Inc. Specific projects and financial details were not disclosed.

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

The Pierre Robin Mandible is Hypoplastic and Morphologically Abnormal.

For Pierre Robin sequence (PRS) patients, there is incomplete characterization of 3D differences and effects of mandibular distraction osteogenesis (MDO) on the mandible compared to normal controls.

Ameloblastic Fibro-Odontoma of the Maxilla in a Pierre-Robin Sequence Patient.

Pierre Robin sequence (PRS) is a rare disorder classically observed as a triad of features including micrognathia, glossoptosis, and upper airway obstruction. It is associated with a syndrome in about...

Postoperative Respiratory Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations.

In cleft palate surgery, there is currently no consensus on the management of patients with Pierre Robin Sequence (PRS). The authors aimed to evaluate the treatment strategy of cleft palate in our cen...

A Review on Ethno-Medicinal and Pharmacological Activities of Sphenocentrum jollyanum Pierre.

Sphenocentrum jollyanum Pierre is a member of a diverse family of plants known as Menispermaceae. They are famous for a plethora of important biological functions. S. jollyanum is a shrub native to th...

The Arago Laboratory of Banyuls and some of its Academicians.

Since its founding in 1881 by Henri de Lacaze-Duthiers (1821-1901), the Arago Laboratory of Banyuls has been one of the three marine stations of the University Pierre and Marie Curie-Paris 6. It is lo...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

The Healthy Options Feasibility Study

The investigators hypothesize that having health care providers other than physicians within a "Groupe de Médecine de Famille" conduct cardiovascular risk assessments and teach lifestyle ...

Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke

The last marketed thrombectomy devices, named stentretriever, permit a better and faster recanalization in patient with a stroke. The REVIVETM SE is a device designed to restore the brain ...

A Comparison Between Two Video Laryngoscopes,in Successfully Intubating Pediatric Mannequins w/wo Difficult Airways

The study is a randomized crossover study where anesthesia practitioners will intubate three different pediatric infant mannequins (normal airway, anterior larynx, Pierre Robin syndrome an...

Companies [58 Associated Companies listed on BioPortfolio]

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

Laboratoires Pierre Fabre S A

Nil

CENTRE D’IMMUNOLOGIE PIERRE FABRE

Located in France, close to the biotech heart of Geneva, the CIPF is a part of Pierre FABRE Laboratories (over 9000 people in France and overseas). Created in 1990, our Research Centre - 100 collabor...

Groupe SEB

The world leader in small domestic equipment, Groupe SEB operates in more than 120 countries with a unique portfolio of top brands marketed through multi-format retailing. Selling some 170 million pro...

More Information about "Groupe Pierre Fabre" on BioPortfolio

We have published hundreds of Groupe Pierre Fabre news stories on BioPortfolio along with dozens of Groupe Pierre Fabre Clinical Trials and PubMed Articles about Groupe Pierre Fabre for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Groupe Pierre Fabre Companies in our database. You can also find out about relevant Groupe Pierre Fabre Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record